Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn wealth building best practices tailored for young adults to kickstart your financial journey. Begin your path to success today.
15,531 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
What could drive Entravision's 2025 earnings, and what should investors watch next? This guide breaks down the driver...
As 2026 budget cycles unfold, investors are rethinking how the weapons that built army legacy translate into today’s ...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
Boards are rethinking CEO selection, prioritizing agility and AI fluency over years on the job. The shift could upend...
U.S. prosecutors seek october 2026 retrial for Tornado Cash co-founder Roman Storm after a hung jury halted the first...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
Geopolitics around Iran’s Strait Hormuz could reshape energy prices in Europe again. Here’s what households need to k...
As velocity financial readies its quarterly release, investors seek clues about growth, profitability, and risk. This...
Investors are eyeing Vera Bradley's 2026 path as it rhythms through product launches, wholesale relationships, and di...
AI is reshaping hiring in three AI-driven domains, even as revenue growth decouples from headcount. The shift signals...